Quantcast
Close Window
   
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
 
or the FDA, CDC, ACA, NIH, etc...
 
Now THAT sure would save a shit-load of money, wouldn't it ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
Thanks to all who help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU and the ones YOU love.
 
Thank you,   
Emily
 
$.00         
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
 
Thank you,
Emily
 
$.00         

Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
Here we go again - another drug with false and misleading marketing that downplays risks. Gee, another set of lawsuits waiting to happen :o)

Keywords: jnj, johnson and johnson, johnson + johnson, J&J, xarelto, FDA, marketing, violation
Date Created/Edited: July 21, 2013
 

Most Recent Content....
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017 (2017, November 17)
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
talc, risperdal, asr, xarelto, baby powder, tvt, mesh, lawsuit
 
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
Gee, here we go again. Xarelto is a Johnson & Johnson drug approved for certain conditions by the FDA since introduced in 2011. On June 6, 2013, the United States Food and Drug Administration (USFDA) sent Johnson & Johnson a warning letter for false advertising. In the FDA letter to Johnson & Johnson states, "The print ad is false or misleading because it minimizes the risks associated with Xarelto and makes a misleading claim."
 
This was also the case withLevaquin, Risperdal and even Exelon - all with FDA violations of false or misleading claims in their advertising material and all under the direct control of current CEO Alex Gorsky. Our doctors are literally being lied to regarding the safety and effectiveness of J&J pharmaceutical products and medical devices. How do you think that might affect your physician's choices for your treatment?
 
If you look at the information from the first article I wrote on Xarelto, you'll realize that if a doctor knew the truth they'd never prescribe the drug. For example, Xarelto is not proven to effectively treat the conditions for which it is prescribed. Xarelto costs more than known effective and currently available drugs. Xarelto has more side effects than currently available, proven-effective drugs. So basically, the insert should state that it is not proven, is more expensive and has more side effects. Yeah, I can see docs rushing to prescribe this based on the truth.
 
But then again, this is another drug slammed though a corrupt USFDA by The King of Corruption, JNJ Alex Gorsky. Xarelto is another drug brought to you by a corporation, Johnson & Johnson that used Freedom of Speech, or a Constitutional right to lie, as a defense with regard to the Arkansas verdict of $1.2 BILLION in restitution for Risperdal.
 
I wonder, if Johnson & Johnson products are so great, why do they have to lie about them to sell them? Would they be able to sell their products if they told the truth? With yet another product that safety data was not submitted to the FDA, less effective than existing products, more expensive than existing products and has more side effects than existing products, well, I doubt it.
 

Original Article, "Xarelto by Johnson & Johnson is Likely Another OverHyped Dud"
UPDATE: MAY 24, 2012
The FDA showed intelligence for a change and did not approve Xarelto for expanded use explaining that Agency advisers say there's not enough data in company trials on benefit for high-risk patients. The article contains additional information regarding the missing data of the outcome of a 15,000 patient clinical study. One of the FDA reviewers suggested that the missing data may indicate that Xarelto is not effective as J&J claims for expanded use in treating acute coronary syndrome.
 
Original article:
Here we go again - another supposed blockbuster drug with issues but will get pushed through FDA anyway. Xarelto is a blood thinner used during major surgeries to reduce the risks of blood clots. It is now being pushed through FDA for regular use to reduce the risk of blood clots in people with acute coronary syndrome. However, due to missing data, "The staff appeared united in the view that the data did not prove Xarelto reduced the risk of death in patients with acute coronary syndrome..." according to Reuters.
 
In the same article, it is clearly stated that 12% of those in clinical trials dropped out. ANNNND - there were three deaths while on the drug that were excluded from information submitted to the FDA. Gee, what's this? If the people in the clinical trial DIE from the drug, they don't count? OMG. No wonder there are so many lawsuits against J&J!
 
According to the available FDA information, Xarelto was not demonstrated to be more effective than currently available drugs - but has more side effects as well as a higher cost. And we all know what more side effects means, they can sell more drugs to deal with the side effects.
 
Missing data, 12% dropout rate (or lost track of) and three deaths should be a sure sign that J&J knows there are issues with the drug. In addition, the expectation of such a large number of recipients to total over a billion in sales, although the drug should not be prescribed to those under 18, over 65, anyone with high blood pressure, etc, as well as the known and published side effects - um, how, exactly, could this be a 'blockbuster'? What I see is more off-label marketing to meet the sales goals and more harm with the resulting lawsuits. Oh, joy. Higher health care costs to pay for yet another 'blockbuster'. More like 'economy buster'.
 
Resources:
1. Zarna Patel and Amy Toscano (2013, June 6). FDA WARNING LETTER. Office of Prescription Drug Promotion, United States Food and Drug Administration. Retrieved from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM357833.pdf
 
2. Emily Patterson (2013, May 8). List of Reasons Johnson & Johnson CEO Alex Gorsky Should Immediately Resign. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/alex_gorsky_resignation.shtml
 
3. Emily Patterson (2012, November 9). Johnson & Johnson CEO Alex Gorsky's Career Long Cloud of Corruption. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/alex_gorsky_corruption.shtml
 
4. Emily Patterson (2013, June 20). Johnson & Johnson Defense Against $1.2 Billion Arkansas Risperdal: We Have a Constitutional Right to Lie. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/right_to_lie.shtml
 
5. Emily Patterson (2012, April 13). Johnson & Johnson Risperdal: Broken Laws and Side Effects. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/risperdal.shtml
 
6. Emily Patterson (2012, May 23). Xarelto by Johnson & Johnson is Likely Another OverHyped Dud. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/xarelto.shtml
 
7. HealthDay Correspondent (2012, May 23). FDA Panel Votes Against New Use for Blood Thinner Xarelto. US News and World Report. Retrieved from http://health.usnews.com/health-news/news/articles/2012/05/24/fda-panel-votes-against-new-use-for-blood-thinner-xarelto
 
8. Anna Yukhananov (2012, May 21). FDA staff sends mixed message on J&J drug Xarelto. Reuters. Retrieved from http://www.reuters.com/article/2012/05/21/us-fda-johnson-xarelto-idUSBRE84K0M220120521?feedType=RSS&feedName=healthNews&utm_source=twitterfeed&utm_medium=twitter&utm_campaign=Feed%3A+reuters%2FhealthNews+%28Reuters+Health+News%29
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries